Future-proofing drug discovery through flexible platforms
The ability of a drug discovery solution to change and adapt is essential to meet the evolving needs of patients, ...
Cambridge, UK – May 15, 2023 – Torx® Software Limited, provider of Torx for management of small molecule discovery chemistry, announces the roll-out of its spring release to all customers, further enhancing the CRO management capabilities.
The modular, cloud-native Torx platform enables chemistry teams to collaborate and share molecules, both internally and with contract research organizations (CROs) around the world.
“We know that managing CROs can be a major challenge for both biotechnology and large pharmaceutical companies,” said Dr. Tim Cheeseright, CEO, Torx Software. “That’s why we’ve made it our top priority to make Torx the most user-friendly and efficient way to manage projects with CROs.”
The spring update to Torx includes several enhancements which make CRO collaboration, communication and management even easier:
“Identifying compounds which have stalled during synthesis is a vital new capability for Torx.” said Dr. Martin Harrison, CTO, Torx Software. “It enables medicinal chemists to quickly identify bottlenecks in their DMTA cycle times which are lost in traditional Excel or PowerPoint based CRO communication and management systems.”